Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oligoprogression”

57 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 57 results

Testing effectiveness (Phase 2)Study completedNCT03696277
What this trial is testing

SAbR For Oligo-Progressive Renal Cell Cancer.

Who this might be right for
Oligoprogressive Renal Cell Carcinoma
University of Texas Southwestern Medical Center 21
Testing effectiveness (Phase 2)Looking for participantsNCT05990192
What this trial is testing

SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy

Who this might be right for
Ovarian Cancer Recurrent
Institute of Cancer Research, United Kingdom 42
Testing effectiveness (Phase 2)Looking for participantsNCT06260033
What this trial is testing

Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Estrogen Receptor-Positive Breast CarcinomaMetastatic Breast Carcinoma
City of Hope Medical Center 18
Testing effectiveness (Phase 2)WithdrawnNCT06331585
What this trial is testing

Effect of Low-dose Radiotherapy on Tumor Immune Microenvironment in Oligometastases of NSCLC After Immunotherapy

Who this might be right for
Low-dose RadiotherapyTumor MicroenvironmentNon-Small Cell Lung Cancer
Hetian District People's Hospital
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07333651
What this trial is testing

125I Seed Implantation Plus Systemic Therapy for Oligoprogressive NSCLC or Colorectal Cancer

Who this might be right for
Oligometastatic Disease
Li Min 90
Testing effectiveness (Phase 2)Looking for participantsNCT04299646
What this trial is testing

A Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases

Who this might be right for
Metastatic Renal Cell CarcinomaRadiotherapy
Centre Francois Baclesse 77
Not applicableLooking for participantsNCT04115254
What this trial is testing

Stereotactic Magnetic Resonance Guided Radiation Therapy

Who this might be right for
Pancreas CancerLung CancerRenal Cancer+10 more
Dana-Farber Cancer Institute 397
Not applicableLooking for participantsNCT07121335
What this trial is testing

SMC Radiation Oncology SABR Cohort for Oligometastasis

Who this might be right for
Stereotactic Body Radiation Therapy (SBRT)OligometastasisOligoprogression+2 more
Samsung Medical Center 60
Early research (Phase 1)Looking for participantsNCT03546829
What this trial is testing

Safety Trial of Antimicrobial Therapy and Precision Radiation Therapy in Patients With Oligoprogressive Non-small Cell Lung Cancer

Who this might be right for
Early Stage Non-Small Cell Lung Cancer
Abramson Cancer Center at Penn Medicine 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06592612
What this trial is testing

Second-line Systemic Therapy Combined with SBRT for HCC with Oligoprogression After Standard First-line Systemic Treatment

Who this might be right for
Hepatocellular CarcinomaOligoprogression
Sun Yat-sen University 70
Large-scale testing (Phase 3)Looking for participantsNCT06367972
What this trial is testing

Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP)

Who this might be right for
OligoProgressive Metastatic Disease
M.D. Anderson Cancer Center 400
Testing effectiveness (Phase 2)Looking for participantsNCT04070209
What this trial is testing

Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)

Who this might be right for
Metastatic Prostate CancerCastration-resistant Prostate Cancer
Sir Mortimer B. Davis - Jewish General Hospital 66
Testing effectiveness (Phase 2)Looking for participantsNCT07038304
What this trial is testing

The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Cancer (Adenocarcinoma)OligoProgressive Metastatic DiseaseCastration Resistant Metastatic Prostate Cancer+1 more
University Medical Center Groningen 35
Testing effectiveness (Phase 2)Study completedNCT02759835
What this trial is testing

Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib

Who this might be right for
Lung AdenocarcinomaLung Neoplasms
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT03808662
What this trial is testing

Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung

Who this might be right for
TNBC - Triple-Negative Breast CancerTriple Negative Breast CancerNSCLC+4 more
Memorial Sloan Kettering Cancer Center 107
Testing effectiveness (Phase 2)Looking for participantsNCT05830058
What this trial is testing

Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

Who this might be right for
Lung Non-Small Cell CarcinomaMalignant Solid NeoplasmMelanoma+1 more
City of Hope Medical Center 32
Large-scale testing (Phase 3)Looking for participantsNCT06585007
What this trial is testing

Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer

Who this might be right for
Castration-resistant Prostate CancerOligoprogressive
Universitaire Ziekenhuizen KU Leuven 246
Not applicableLooking for participantsNCT05102747
What this trial is testing

Stereotactic Radiotherapy in Oligometastatic Brain Disease: a Randomised Phase III Study Comparing Hypofractionated Stereotactic Radiation Therapy (3*10 Gy) to the Historical Single-dose Radiosurgery (1*20 to 25 Gy) With Medico-economic Evaluation.

Who this might be right for
Brain MetastasisOligoprogression
Centre Francois Baclesse 504
Testing effectiveness (Phase 2)Looking for participantsNCT04892953
What this trial is testing

Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy

Who this might be right for
Stage III Lung Cancer AJCC v8Stage III Lung Non-Small Cell Cancer AJCC v7Stage IIIA Lung Cancer AJCC v8+4 more
M.D. Anderson Cancer Center 51
Testing effectiveness (Phase 2)UnknownNCT04970693
What this trial is testing

Furmonertinib Combined With Radiotherapy for Non-small Cell Lung Cancer With Oligoprogression

Who this might be right for
Non-small Cell Lung CancerOligoprogressive
Sun Yat-sen University 64
Load More Results